当前位置: 首页 > 期刊 > 《中国现代医生》 > 2019年第11期
编号:13383688
PCR联合HPV检测在宫颈癌筛查中的应用(4)
http://www.100md.com 2019年4月15日 《中国现代医生》 2019年第11期
     [15] Liu G,Sharma M,Tan N,et al.HIV-positive women have higher risk of HPV infection,precancerouslesions,and cervical cancer:A systematic review and meta-analysis[J].Aids,2018,32(6):1245-1378.

    [16] Mejía L,Mu?觡oz D,Trueba G,et al.Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women[J].Journal of Medical Virology,2016,88(12):2021-2278.

    [17] 王晓光,辛志峰,李娜,等.人乳头瘤病毒检测与薄层液基细胞学技术在宫颈癌筛查中的应用[J].现代妇产科进展,2016,25(2):140-142.

    [18] Jiménez-Wences H,Martínez-Carrillo DN,Peralta-Zara-goza O,etal.Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection[J].Oncology Reports,2016,35(4):2297-2389.

    [19] 張淼,周秀春,张冠群.人乳头瘤病毒检测及TCT检查在宫颈癌筛查中的临床价值研究[J].现代预防医学,2016,43(5):836-838.

    [20] Wang X,Cheng K,Han Y,et al.Effects of Psoralen as an Anti-tumor Agent in Human Breast Cancer MCF-7/ADR Cells[J].Biological & Pharmaceutical Bulletin,2016,39(5):815-822.

    (收稿日期:2018-10-28), http://www.100md.com(姚千红 徐舜 赵倩倩)
上一页1 2 3 4